Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy.
Year: 1999
Type: article
Source: PubMed
Authors: X Z Wang, J R Beebe, L Pwiti, A Bielawska, M J Smyth
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1812553909